Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis

Purpose: To report panuveitis with exudative retinal detachments in a healthy 27-year-old woman with biallelic mutations in the RPE65 gene, who underwent bilateral sequential gene therapy with subretinal administration of voretigene neparvovec-rzyl. Observations: Visual acuity improved for 30 days a...

Full description

Bibliographic Details
Main Authors: Alcina K. Lidder, Stephanie Choi, Yasha S. Modi, Scott E. Brodie, Janet L. Davis, Ninel Z. Gregori, Byron L. Lam
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993623000877
_version_ 1827591517791846400
author Alcina K. Lidder
Stephanie Choi
Yasha S. Modi
Scott E. Brodie
Janet L. Davis
Ninel Z. Gregori
Byron L. Lam
author_facet Alcina K. Lidder
Stephanie Choi
Yasha S. Modi
Scott E. Brodie
Janet L. Davis
Ninel Z. Gregori
Byron L. Lam
author_sort Alcina K. Lidder
collection DOAJ
description Purpose: To report panuveitis with exudative retinal detachments in a healthy 27-year-old woman with biallelic mutations in the RPE65 gene, who underwent bilateral sequential gene therapy with subretinal administration of voretigene neparvovec-rzyl. Observations: Visual acuity improved for 30 days after surgery as oral corticosteroids were tapered. At postoperative week 6, vision declined due to sudden onset uveitis and exudative retinal detachments in both eyes. HLA Class II typing revealed the haplotype associated with sympathetic ophthalmia and Vogt-Koyanagi-Harada (VKH). The inflammation improved after corticosteroid, mycophenolate mofetil, and adalimumab therapy while vision remained poor. Conclusions and Importance: Surgically-induced sympathetic ophthalmia is a plausible explanation for the clinical findings; surgery of both eyes within one week would conceal the inciting eye. VKH or inflammation related to the gene therapy are other possible etiologies but severe bilateral panuveitis has not been reported with voretigene neparvovec-rzyl. Informed consent for gene therapy surgery should include a discussion of the rare complication of sympathetic ophthalmia following vitrectomy surgery.
first_indexed 2024-03-09T01:33:51Z
format Article
id doaj.art-05675087d50e47d2afc8f087a3df93aa
institution Directory Open Access Journal
issn 2451-9936
language English
last_indexed 2024-03-09T01:33:51Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj.art-05675087d50e47d2afc8f087a3df93aa2023-12-09T06:07:05ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362023-12-0132101879Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital AmaurosisAlcina K. Lidder0Stephanie Choi1Yasha S. Modi2Scott E. Brodie3Janet L. Davis4Ninel Z. Gregori5Byron L. Lam6Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United StatesDepartment of Ophthalmology, New York University Grossman School of Medicine, New York, NY, United StatesDepartment of Ophthalmology, New York University Grossman School of Medicine, New York, NY, United StatesHarkness Eye Institute, Columbia University, New York, NY, United StatesBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United StatesBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United StatesBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Corresponding author. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL, 33136, United States.Purpose: To report panuveitis with exudative retinal detachments in a healthy 27-year-old woman with biallelic mutations in the RPE65 gene, who underwent bilateral sequential gene therapy with subretinal administration of voretigene neparvovec-rzyl. Observations: Visual acuity improved for 30 days after surgery as oral corticosteroids were tapered. At postoperative week 6, vision declined due to sudden onset uveitis and exudative retinal detachments in both eyes. HLA Class II typing revealed the haplotype associated with sympathetic ophthalmia and Vogt-Koyanagi-Harada (VKH). The inflammation improved after corticosteroid, mycophenolate mofetil, and adalimumab therapy while vision remained poor. Conclusions and Importance: Surgically-induced sympathetic ophthalmia is a plausible explanation for the clinical findings; surgery of both eyes within one week would conceal the inciting eye. VKH or inflammation related to the gene therapy are other possible etiologies but severe bilateral panuveitis has not been reported with voretigene neparvovec-rzyl. Informed consent for gene therapy surgery should include a discussion of the rare complication of sympathetic ophthalmia following vitrectomy surgery.http://www.sciencedirect.com/science/article/pii/S2451993623000877Subretinal gene therapyLeber congenital amaurosisVogt-koyanagi-harada diseaseSympathetic ophthalmiaRPE65-Associated inherited retinal diseasePanuveitis
spellingShingle Alcina K. Lidder
Stephanie Choi
Yasha S. Modi
Scott E. Brodie
Janet L. Davis
Ninel Z. Gregori
Byron L. Lam
Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
American Journal of Ophthalmology Case Reports
Subretinal gene therapy
Leber congenital amaurosis
Vogt-koyanagi-harada disease
Sympathetic ophthalmia
RPE65-Associated inherited retinal disease
Panuveitis
title Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
title_full Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
title_fullStr Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
title_full_unstemmed Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
title_short Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
title_sort bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec rzyl for rpe65 leber congenital amaurosis
topic Subretinal gene therapy
Leber congenital amaurosis
Vogt-koyanagi-harada disease
Sympathetic ophthalmia
RPE65-Associated inherited retinal disease
Panuveitis
url http://www.sciencedirect.com/science/article/pii/S2451993623000877
work_keys_str_mv AT alcinaklidder bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis
AT stephaniechoi bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis
AT yashasmodi bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis
AT scottebrodie bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis
AT janetldavis bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis
AT ninelzgregori bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis
AT byronllam bilateralexudativeretinaldetachmentsaftersubretinalgenetherapywithvoretigeneneparvovecrzylforrpe65lebercongenitalamaurosis